Pharmaceutical

NHS England offers MSD belzutifan for von Hippel-Lindau disease

NHS England has announced the availability of MSD UK’s belzutifan, a take-at-home pill for patients with von Hippel-Lindau disease.

Sep 6, 2024 - 04:00
NHS England offers MSD belzutifan for von Hippel-Lindau disease
NHS England has announced the availability of MSD UK’s belzutifan, a take-at-home pill for patients with von Hippel-Lindau disease.
Read the original article

Tags:

Previous Article

IN8bio cuts staff and pipeline to focus on AML cell therapy

Next Article

UK bans xylazine and 21 other substances to fight drug abuse

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

CMS sets up negotiating framework for expensive sickle cell disease gene therapies

CMS sets up negotiating framework for expensive sickle ...

Jan 31, 2024

STAT+: Key House Republican escalates rhetoric against PBMs

STAT+: Key House Republican escalates rhetoric against ...

Jun 14, 2023

Can Musk’s BCI company Neuralink be trusted to put chips in your brain?

Can Musk’s BCI company Neuralink be trusted to put chip...

Jan 31, 2024